Arkolith/Insider Trading/CHRS/Form 4

Stilwell McDavid

Chief Financial OfficerCoherus BioSciences, Inc. (CHRS) · full profile →Form 4 · filed Oct 19, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$59K
Net Open-Market Flow
-$59K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2021Sell(S)4K$16.80$59K32K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-21-018470) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML